Latest News in the pharma Industry

Biopharma News

Pall introduces proprietary bioreactor control system

Pall introduces proprietary bioreactor control system

27 Jul 2017

The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide.

Read more 
Valeant launches Siliq Injection in US

Valeant launches Siliq Injection in US

27 Jul 2017

Dermatology unit is rebranded Ortho Dermatologics.

Read more 
Merck launches Remicade biosimilar for all eligible indications, in the US

Merck launches Remicade biosimilar for all eligible indications, in the US

24 Jul 2017

The biosimilar's list price will represent a 35% discount to the current list price of Remicade.

Read more 
Lilly backs Nektar Therapeutics' novel immunological therapy

Lilly backs Nektar Therapeutics' novel immunological therapy

24 Jul 2017

NKTR-358 has the potential to treat a number of autoimmune and other chronic inflammatory conditions.

Read more 
GSK delivers double-edged sword

GSK delivers double-edged sword

19 Jul 2017

Company announces investments, the sale of several products and a proposal to close a UK manufacturing site.

Read more 
FDA committee recommends approval of Mylan and Biocon's proposed biosimilar trastuzumab

FDA committee recommends approval of Mylan and Biocon's proposed biosimilar trastuzumab

16 Jul 2017

Vote marks first proposed biosimilar trastuzumab to be recommended by the committee.

Read more 
FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

12 Jul 2017

Blincyto is the first and only Bispecific T cell Engager (BiTE) immunotherapy to demonstrate superior overall survival versus standard of care chemotherapy.

Read more 
Sanofi to acquire Protein Sciences

Sanofi to acquire Protein Sciences

11 Jul 2017

Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur's portfolio.

Read more 
BIOCAD’s rituximab biosimilar to receive MA in India

BIOCAD’s rituximab biosimilar to receive MA in India

4 Jul 2017

First shipment of BIOCAD’s Acellbia to India is scheduled for September 2017.

Read more 
FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

2 Jul 2017

First-and-only fully human monoclonal anti-epidermal growth factor receptor antibody approved by the FDA for this patient population.

Read more 
Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by CHMP

Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by CHMP

23 Jun 2017

If approved, Imraldi will be the third anti-TNF biosimilar in Biogen’s portfolio in Europe.

Read more 
FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

19 Jun 2017

Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours and is the number one prescribed agent by oncologists for this indication in the US.

Read more